LANZILLOTTA, MARCO
 Distribuzione geografica
Continente #
EU - Europa 758
NA - Nord America 381
AS - Asia 203
OC - Oceania 9
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.354
Nazione #
US - Stati Uniti d'America 377
IT - Italia 366
SE - Svezia 238
CN - Cina 85
SG - Singapore 78
RU - Federazione Russa 70
FI - Finlandia 32
IN - India 16
DE - Germania 15
GB - Regno Unito 12
IE - Irlanda 10
NZ - Nuova Zelanda 7
CA - Canada 4
HK - Hong Kong 4
PH - Filippine 4
TR - Turchia 4
IL - Israele 3
PK - Pakistan 3
UA - Ucraina 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
FR - Francia 2
GR - Grecia 2
IR - Iran 2
JP - Giappone 2
NL - Olanda 2
TN - Tunisia 2
CZ - Repubblica Ceca 1
EU - Europa 1
KR - Corea 1
RO - Romania 1
TW - Taiwan 1
Totale 1.354
Città #
Shanghai 72
Lawrence 69
Princeton 69
New York 46
Milan 42
Moscow 41
Singapore 36
Helsinki 30
Ashburn 29
Boardman 28
Rome 22
Pune 15
Cagliari 13
Seattle 13
Turin 13
Rovigo 10
Dublin 9
Galliate 9
London 9
Vaprio d'Adda 8
Verona 8
Bari 7
Florence 6
Naples 6
Auckland 5
Bergamo 5
Mezzolombardo 5
Mira 5
Vittoria 5
Alessandria 4
Borås 4
Genoa 4
Istanbul 4
Mantova 4
Minerbio 4
Quezon City 4
Sesto San Giovanni 4
Trino 4
Angera 3
Gallarate 3
Kyiv 3
Los Angeles 3
Padova 3
Piana degli Albanesi 3
Salt Lake City 3
San Lazzaro di Savena 3
Siena 3
Vimercate 3
Ancona 2
Andover 2
Athens 2
Atlanta 2
Bacoli 2
Benken 2
Bologna 2
Brescia 2
Calci 2
Campobasso 2
Casoria 2
Castel Madama 2
Cosenza 2
Duino-Aurisina 2
Feilding 2
Frankfurt am Main 2
Hong Kong 2
Islamabad 2
Lenta 2
Livorno 2
Ljungby 2
Melbourne 2
Messina 2
Parabiago 2
Pedrengo 2
Pescara 2
Portogruaro 2
Ravenna 2
Reggio Emilia 2
Rimini 2
Rozzano 2
Secaucus 2
Segrate 2
Sessa Aurunca 2
Tel Aviv 2
Tirana 2
Toronto 2
Torre Del Greco 2
Trieste 2
Venice 2
Vero Beach 2
Aachen 1
Aci Catena 1
Amsterdam 1
Beaverton 1
Birmingham 1
Bolzano 1
Brighton 1
Buk-gu 1
Cambridge 1
Cedar Crest 1
Central 1
Totale 794
Nome #
PACHIMENINGITE IPERTROFICA IGG4-CORRELATA: DIAGNOSI E RISPOSTA TERAPEUTICA 194
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 45
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 40
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 34
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 33
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO 31
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 30
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 29
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 27
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 25
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 25
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 24
A cd8 alpha-negative subset of cd4+slamf7+ cytotoxic t cells is expanded in patients with igg4-related disease and decreases following glucocorticoid treatment 24
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 23
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 23
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 21
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 21
A unique case of IgG4-related pachymeningitis treated with intrathecal rituximab 21
Methotrexate as induction of remission therapy for localized manifestations of IgG4-Related Disease. 21
EFFETTI DEL PREDNISONE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI CON MALATTIA IgG4-CORRELATA 20
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 20
IDENTIFICAZIONE DI UNA SOTTOPOPOLAZIONE CD8- DI LINFOCITI CD4 CITOTOSSICI ESPANSA NEI PAZIENTI CON MALATTIA IGG4-CORRELATA E RESPONSIVA ALLA TERAPIA CON GLUCOCORTICOIDI 20
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease 19
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE 19
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 19
Advances in the diagnosis and management of IgG4 related disease. 19
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 18
Urgent manifestations of immunoglobulin G4-related disease 18
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 17
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 17
Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. 16
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 16
INFLAMMATORY ACTIVITY OF IgG4-RELATED DISEASE LESIONS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY CORRELATES WITH CIRCULATING PLASMABLASTS LEVELS 16
INCREASE OF CIRCULATING MEMORY B CELLS AFTER GLUCOCORTICOID-INDUCED REMISSION PREDICTS IGG4-RELATED DISEASE RELAPSE 16
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES 16
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 15
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 15
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 15
IGG4 RELATED HYPERTROPHIC PACHYMENINGITIS: DIAGNOSTIC APPROACH AND THERAPEUTIC OUTCOMES 15
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease 15
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis 14
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circula-ting plasmablasts in IgG4-related type 1 au-toimmune pancreatitis and other organs 14
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE 14
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease 14
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 13
EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE 13
MALATTIA IGG4-CORRELATA: ESPERIENZA QUINQUENNALE MONOCENTRICA SU UNA CORTE ITALIANA DI 150 PAZIENTI (2013 - 2018) 13
EFFETTI DELLA TERAPIA CON PREDNISONE E METHOTREXATE SULLE SOTTOPOPOLAZIONI B LINFOCITARIE NEI PAZIENTI AFFETTI DA MALATTIA-IgG4 CORRELATA 13
Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort 12
Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients 12
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE 12
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 12
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 11
Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis 11
CLINICAL PHENOTYPES OF IGG4-RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL, IMMUNOLOGICAL AND PROGNOSTIC FEATURES 11
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 11
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 11
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 11
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 10
EFFECTS OF GLUCOCORTICOIDS AND METHOTREXATE-BASED THERAPEUTIC REGIMENS ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 10
CIRCULATING PLASMABLASTS LEVELS REFLECT INFLAMMATORY ACTIVITY IN IGG4-RELATED DISEASE LESIONS AS ASSESSED BY QUANTITATIVE POSITRON EMISSION TOMOGRAPHY 10
An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index 10
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 9
METHOTREXATE AS INDUCTION OF REMISSION THERAPY FOR LOCALIZED MANIFESTATIONS OF IGG4-RELATED DISEASE 9
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 8
Immunology of IgG4-related disease 8
Methotrexate as induction of remission the-rapy for IgG4-Related type 1 Autoimmune Pancreatitis 8
IGG4-RELATED DISEASE IN ITALY: RESULTS FROM A MONOCENTRIC COHORT OF 150 PATIENTS (2013–2018) 8
FENOTIPI CLINICI DELLA MALATTIA IGG4 CORRELATA: ANALISI CROSS-SECTIONAL DI UNA CORTE INTERNAZIONALE 8
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 8
IgG4-RELATED DISEASE PRESENTATION REQUIRES ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES 8
Serum IgG4 level predicts COVID-19 related mortality 7
Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply 7
Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse 7
EFFECTS OF COMBINED THERAPY WITH PREDNISONE AND METHOTREXATE ON B CELL SUBPOPULATIONS IN PATIENTS WITH IGG4-RELATED DISEASE 7
DECONSTRUCTING LA MALATTIA DA IGG4 CON INTERESSAMENTO DELLE STRUTTURE MEDIANE: CONFRONTO CON I COMUNI “MIMICKERS” 7
Association of IgG4-related disease and systemic rheumatic disorders 5
Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease 5
EFFICACIA E SICUREZZA DELLA SOMMINISTRAZIONE INTRATECALE DI RITUXIMAB PER IgG4-RELATED PACHIMENINGITE IPERTROFICA REFRATTARIA 5
Roles of Plasmablasts and B Cells in IgG4-Related Disease: Implications for Therapy and Early Treatment Outcomes 5
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 5
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment 5
HLA-DRB1∗16 and -DQB1∗05 alleles are strongly associated with autoimmune pancreatitis in a cohort of hundred patients 5
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis 4
Totale 1.462
Categoria #
all - tutte 15.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 1 0 0 0 0 0 7 0 0 0 0 0
2020/202121 1 0 1 4 1 8 0 1 1 1 2 1
2021/2022156 0 0 46 12 2 10 7 9 21 15 18 16
2022/2023546 170 93 42 6 12 54 53 40 33 5 12 26
2023/2024593 26 39 69 46 38 88 22 69 6 24 61 105
2024/2025133 133 0 0 0 0 0 0 0 0 0 0 0
Totale 1.462